Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00633516 · ClinicalTrials.gov registry record

A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions

A clinical trial, sponsored by University of California, Irvine.

Completed
Registry status
37
Enrollment target

NCT00633516: Completed study, sponsored by University of California, Irvine.

NCT00633516 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00633516 has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
37 participants
Enrollment target

Study Summary

The incidence of malignant melanoma has increased dramatically in recent decades. In 1930, the lifetime risk of an individual in the United States developing melanoma was 1 in 1,500. This has been exponentially increasing over the years with the risk estimated to be 1 in 75 in 2000 . According to the American Cancer Society, approximately 59,580 new cases of melanoma will be diagnosed in the United States in 2005 and about 7,770 people are expected to die of the disease.

Primary Outcome

Optical Spectroscopy imaging of atypical moles and melanoma to correlate results from the results of the biopsy tissue histology

Interventions

  • DEVICE Optical Spectroscopy

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2008-07
Est. Completion 2013-11
University of California, Irvine

368 total trials

What the finished NCT00633516 record still lists

NCT00633516 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Optical Spectroscopy is the first listed.

NCT00633516 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00633516 about?

NCT00633516 is a clinical study titled "A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions". The incidence of malignant melanoma has increased dramatically in recent decades. In 1930, the lifetime risk of an individual in the United States developing melanoma was 1 in 1,500. This has been exponentially increasing over the years with the risk estimated to be 1 in 75 in 2000 . According to th...

What is the current status of trial NCT00633516?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2008-07. Estimated completion is 2013-11.

What interventions are being tested in trial NCT00633516?

The interventions under investigation include: Optical Spectroscopy (DEVICE).

Who is sponsoring clinical trial NCT00633516?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00633516, the US trial registry maintained by the National Library of Medicine. NCT00633516 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.